Clinical trial Recruiting at 1 site Interventional Ages 6 to 18

Dietary intervention for children with Juvenile Idiopathic Arthritis

Official title: Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis: Interventional, Exploratory Single-center, Randomized, Controlled, Open-label, add-on Study

Run by Meyer Children's Hospital IRCCS · NCT06874608 · Data updated 2026-11-12

This study is testing if a special diet without certain ingredients can help children with Juvenile Idiopathic Arthritis feel better over four weeks.

Quick facts

Study typeInterventional
Ages6 Years to 18 Years
SexAll
Enrollment20 (estimated)
SponsorMeyer Children's Hospital IRCCS
Academic / other
Drugs / interventionsprednisone
Locations1 site (Florence)
StatusRecruiting
StartedDecember 12, 2024
Main results expectedMay 15, 2025
Study endsNovember 15, 2025
Registry record updatedMarch 13, 2025
Trial IDNCT06874608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 18 with a confirmed diagnosis of mild to moderate JIA who have not responded adequately to current pharmacological therapies.

Probably not a fit

Patients requiring systemic immunosuppressive therapy for active uveitis or those on systemic corticosteroids may not benefit from this dietary intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot project evaluates the effectiveness of a complete, polymeric, fiber, lactose, and gluten-free diet in children aged 6 to 18 with Juvenile Idiopathic Arthritis (JIA). The study aims to determine if a 4-week exclusion diet can lead to improvements in disease activity, similar to findings in other inflammatory conditions. Participants will be assessed for their response to the diet using the Juvenile Arthritis Disease Activity Score (JADAS10).

Why it matters

Potential benefit: If successful, this dietary approach could provide a non-pharmacological treatment option for managing symptoms of JIA in children.

How similar studies have gone: Previous studies in other inflammatory diseases have shown promising results with similar dietary interventions, suggesting potential for success in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed diagnosis of juvenile idiopathic arthritis (JIA) in the forms of enthesitis-related arthritis and oligoarticular forms according to the ILAR 2001 criteria (https://medicalcriteria.com/web/reujia/);
* Age between 6 and 18 years (not yet 18);
* Active disease of mild to moderate severity, assessed through the Juvenile - Arthritis Disease Activity Score (JADAS10) tool (Trincianti C. et al., American College Rheumatology, 2021);
* For study groups 2 and 3: failure of ongoing pharmacological therapy at the time of screening, defined as a failure to achieve at least a 20% reduction in JADAS10 values after 3 months of initiating DMARD therapy or biologic medication, or if the disease is inactive on such therapy, a 20% increase in those values;
* Signed informed consent.

Exclusion Criteria:

* Patients requiring systemic immunosuppressive therapy for active uveitis;
* Patients undergoing therapy with systemic corticosteroids (defined as prednisone equivalent \>0.5 mg/kg for \>7 days) or intra-articular corticosteroids in the 3 months prior to enrollment;
* Patients with fecal calprotectin values \> 250 mcg/g at the time of screening;
* Use of antibiotics in the month prior to enrollment.

Where it's running

  • AOU Meyer IRCCS
    Florence, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.